<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27374720</article-id>
      <article-id pub-id-type="pmc">4940498</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2016.36.5.501</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="subheading">
            <subject>General Laboratory Medicine</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>MLL-SEPT5</italic> Fusion Transcript in Two <italic>de novo</italic> Acute Myeloid Leukemia Patients With t(11;22)(q23;q11)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Nana</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Xiaojin</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sheng</surname>
            <given-names>Guangying</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Liang</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wen</surname>
            <given-names>Lijun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yao</surname>
            <given-names>Hong</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Chen</surname>
            <given-names>Suning</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, P.R. China.</aff>
      <author-notes>
        <corresp>Corresponding author: Suning Chen. Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, P. R. China. Tel: +18550036884, Fax: +0512-67780441, <email>chensuning@sina.com</email></corresp>
        <fn id="FN1" fn-type="equal">
          <p><sup>*</sup>N.W. and X.W. contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <volume>36</volume>
      <issue>5</issue>
      <fpage>501</fpage>
      <lpage>503</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>19</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>Rearrangements involving mixed lineage leukemia (MLL) are common chromosome aberrations in infant, pediatric and adult acute leukemia, which are generally associated with poor prognosis. To date, more than 79 partner genes have been identified [<xref rid="B1" ref-type="bibr">1</xref>]. <italic>MLL</italic> fusion partners can be classified into four groups: nuclear proteins (<italic>MLLT3</italic>, <italic>MLLT10</italic>, and <italic>MLLT1</italic>), cytoplasmatic proteins (<italic>GAS7</italic>, <italic>SH3GL1</italic>, <italic>EPS15</italic>, and <italic>MLLT4</italic>), histone acetyltransferases (<italic>EP300</italic>, <italic>CREBBP</italic>), and the septin family (<italic>SEPT2</italic>, <italic>SEPT5</italic>, and <italic>SEPT6</italic>) [<xref rid="B2" ref-type="bibr">2</xref>]. In pediatric and adult AML, the most frequent fusion partners are represented by <italic>MLLT3-AF9</italic> (9p22), <italic>MLLT10-AF10</italic> (10p12), <italic>ELL</italic> (19p13.1), <italic>MLLT4-AF6</italic> (6q27), and <italic>MLLT1-ENL</italic> (19p13.3) [<xref rid="B1" ref-type="bibr">1</xref><xref rid="B3" ref-type="bibr">3</xref>]. However, as a partner gene, the SEPT5 gene has been reported in only five AML cases (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
    <p>Here we present two cases of <italic>de novo</italic> AML with <italic>MLL-SEPT5</italic> transcript. Chromosomal analysis revealed a karyotype of 46, XX/XY, t(11;22)(q23;q11.2). Reverse transcription polymerase chain reaction (RT-PCR) analysis indicated an <italic>MLL-SEPT5</italic> fusion transcript. Sanger sequencing of the PCR product confirmed the fusion between <italic>MLL</italic> and <italic>SEPT5</italic>. Notably, a new fusion transcript between <italic>MLL</italic> exon 8 and <italic>SEPT5</italic> intron 2 was detected in one of the patients.</p>
    <p>Patient 1 was a 21-yr-old man who presented with fever, oral ulcer, and tonsillitis. His hemoglobin level was 8.5 g/dL, white blood cell count was 35.45&#xD7;10<sup>9</sup>/L, and platelet count was 29&#xD7;10<sup>9</sup>/L. Bone marrow aspiration was hypercellular, containing 81% blasts. Immunophenotypic analysis showed that the blasts were positive for CD45, CD33, CD117, CD15, and HLA-DR, but negative for other markers. Cytogenetic studies revealed the karyotype of 46, XY, t(11;22)(q23;q11.2) [8]/46,XY [2]. Fluorescence <italic>in situ</italic> hybridization analysis using a MLL-specific probe showed a split in the <italic>MLL</italic> gene (<xref ref-type="fig" rid="F1">Fig. 1</xref>). He received three courses of induction chemotherapy in our hospital followed by a mother-to-son haploidentical bone marrow transplantation. To date, he is in complete remission.</p>
    <p>To validate <italic>MLL-SEPT5</italic> existence, we performed RT-PCR and direct DNA sequencing. Total RNA was extracted from the bone marrow cells using TRIzol reagent (Invitrogen, Paisley, UK) and chloroform. cDNA was obtained by RT-PCR using the M-MLV reverse transcriptase (Promega, Madison, WI, USA). The resulting cDNA was amplified by PCR using 2&#xD7;Hieff PCR Master Mix (Yaeson, Shanghai, China) and the following primers: 5'-GCTCCACCCATCAAACCAAT-3' from exon 5 of <italic>MLL</italic> and 5'-TTCTTCTCAATGTCCACCGT-3' from exon 4 of <italic>SEPT5</italic> (<xref ref-type="fig" rid="F2">Fig. 2</xref>). PCR products were sequenced on both strands by using an Applied Biosystems ABI 3730 XL DNA analyzer (Thermo Fisher Scientific, Waltham, MA, USA). The sequence was analyzed with Chromas Lite software (version 2.01, Technelysium, Brisbane, Australia). The fusion between <italic>MLL</italic> exon 8 and <italic>SEPT5</italic> intron 2 is indicated by the chromatogram (<xref ref-type="fig" rid="F3">Fig. 3A</xref>). Both breakpoints in the two genes have not been reported previously.</p>
    <p>Patient 2 was a 22-yr-old woman who presented with sore throat, dysphagia, fever, and asthenia. Her hemoglobin level was 11.2 g/dL, platelet count was 54&#xD7;10<sup>9</sup>/L, and white blood cell count was 140&#xD7;10<sup>9</sup>/L, with more than 89% blasts in peripheral blood. Bone marrow smears showed hypercellularity, containing 95.5% blasts. Flow cytometric analysis of the blasts showed the following immunophenotype: CD45, CD14, CD13, and CD33. Karyotype was 46, XX, t(11;22)(q23;q11.2) in all 10 cells examined. She did not receive chemotherapy in our hospital.</p>
    <p><italic>MLL-SEPT5</italic> fusion was verified by the previously used method and the following PCR primers: 5'-CCGGTCAATAAGCAGGAGAA-3' from exon 10 of <italic>MLL</italic> and 5'-CAGCCATGAGTGTGAAG-3' from exon 3 of <italic>SEPT5</italic>. Long distance inverse-PCR is very useful for recognizing unusual cryptic cytogenetic findings, such as a rare <italic>MLL</italic> partner gene, or discrepancies in molecular results that are hard to identify through common molecular diagnostic methods [<xref rid="B4" ref-type="bibr">4</xref>]. Since we have identified the partner gene from previous studies, we utilized RT-PCR and Sanger DNA sequencing to confirm the fusion gene. The results indicate the rearrangement between <italic>MLL</italic> exon 10 and <italic>SEPT5</italic> exon 3 (<xref ref-type="fig" rid="F3">Fig. 3B</xref>).</p>
    <p>We described two new cases of de novo AML with t(11;22)(q23;q11.2), resulting in a <italic>MLL-SEPT5</italic> fusion. To date, five such cases have been reported, including three infants and two adults (<xref ref-type="table" rid="T1">Table 1</xref>). All patients with the <italic>MLL-SEPT5</italic> fusion gene were diagnosed with AML. Tatsumi et al. [<xref rid="B5" ref-type="bibr">5</xref>] examined <italic>SEPT5</italic> expression in 27 leukemia cell lines, including 13 AML and 14 ALL cell lines, which indicated that <italic>SEPT5</italic> expression in AML cell lines was significantly higher than that in ALL. <italic>MLL-SEPT5</italic> fusion gene was important in the leukemogenesis of AML with t(11;22)(q23;q11.2).</p>
    <p>As previously reported, reciprocal <italic>MLL</italic> fusion proteins may have an important role in leukemia development [<xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">7</xref>]. The <italic>MLL-SEPT5</italic> fusion transcript was uncommon and leukemogenesis mechanisms of the fusion protein remain poorly understood. Future studies will be required to elucidate these mechanisms.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hofmann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Burmeister</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gr&#xF6;ger</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Emerenciano</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The MLL recombinome of acute leukemias in 2013</article-title>
          <source>Leukemia</source>
          <year>2013</year>
          <volume>27</volume>
          <fpage>2165</fpage>
          <lpage>2176</lpage>
          <pub-id pub-id-type="pmid">23628958</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cerveira</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bizarro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>MLL-SEPTIN gene fusions in hematological malignancies</article-title>
          <source>Biol Chem</source>
          <year>2011</year>
          <volume>392</volume>
          <fpage>713</fpage>
          <lpage>724</lpage>
          <pub-id pub-id-type="pmid">21714766</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kowarz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hofmann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Renneville</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zuna</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Trka</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New insights to the MLL recombinome of acute leukemias</article-title>
          <source>Leukemia</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>1490</fpage>
          <lpage>1499</lpage>
          <pub-id pub-id-type="pmid">19262598</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Marschalek</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Diagnostic usefulness of genomic breakpoint analysis of various gene rearrangements in acute leukemias: a perspective of long distance- or long distance inverse-PCR-based approaches</article-title>
          <source>Ann Lab Med</source>
          <year>2012</year>
          <volume>32</volume>
          <fpage>316</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="pmid">22779077</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tatsumi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Taki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Taniwaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Taquichi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YZ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The CDCREL1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2001</year>
          <volume>30</volume>
          <fpage>230</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="pmid">11170279</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bursen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schwabe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>R&#xFC;ster</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Henschler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ruthardt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dingermann</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4</article-title>
          <source>Blood</source>
          <year>2010</year>
          <volume>115</volume>
          <fpage>3570</fpage>
          <lpage>3579</lpage>
          <pub-id pub-id-type="pmid">20194896</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emerenciano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kowarz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Karl</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>de Almeida Lopes</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Scholz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bracharz</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional analysis of the two reciprocal fusion genes MLL-NEBL and NEBL-MLL reveal their oncogenic potential</article-title>
          <source>Cancer Lett</source>
          <year>2013</year>
          <volume>332</volume>
          <fpage>30</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">23340173</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Megonigal</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Rappaport</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Lovett</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>KM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1998</year>
          <volume>11</volume>
          <fpage>6413</fpage>
          <lpage>6418</lpage>
          <pub-id pub-id-type="pmid">9600980</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Launay</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Henry</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chapp&#xE9;</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tague</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Boulland</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11)</article-title>
          <source>Leuk Lymphoma</source>
          <year>2014</year>
          <volume>55</volume>
          <fpage>662</fpage>
          <lpage>667</lpage>
          <pub-id pub-id-type="pmid">23725386</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>HX</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Mixed lineage leukemia-septin 5 fusion transcript in de novo adult acute myeloid leukemia with t(11;22)(q23;q11.2): a case report</article-title>
          <source>Oncol Lett</source>
          <year>2014</year>
          <volume>7</volume>
          <fpage>1930</fpage>
          <lpage>1932</lpage>
          <pub-id pub-id-type="pmid">24932261</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>FISH analysis using 11q23 break-apart probe revealed <italic>MLL</italic> rearrangement. Separation of a green and a red signal was observed.</title>
        <p>Abbreviation: MLL, mixed lineage leukemia.</p>
      </caption>
      <graphic xlink:href="alm-36-501-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <title>Identification of the <italic>MLL-SEPT5</italic> fusion transcripts by reverse transcription-PCR. Lane M, 1kb DNA ladder; Lane E, empty control; Lane N, PCR control; Lane P1, patient 1; Lane P2, patient 2.</title>
        <p>Abbreviation: MLL, mixed lineage leukemia.</p>
      </caption>
      <graphic xlink:href="alm-36-501-g002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Fig. 3</label>
      <caption>
        <title>Sequences of junction of the <italic>MLL-SEPT5</italic> chimeric transcript. (A) Patient 1, (B) patient 2.</title>
        <p>Abbreviation: MLL, mixed lineage leukemia.</p>
      </caption>
      <graphic xlink:href="alm-36-501-g003"/>
    </fig>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <title>Reported cases of <italic>de novo</italic> AML with <italic>MLL-SEPT5</italic> fusion</title>
      </caption>
      <alternatives>
        <graphic xlink:href="alm-36-501-i001"/>
        <table frame="hsides" rules="rows">
          <col width="8.73%" span="1"/>
          <col width="14.55%" span="1"/>
          <col width="25.4%" span="1"/>
          <col width="28.04%" span="1"/>
          <col width="23.28%" span="1"/>
          <thead>
            <tr>
              <th valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">Patient</th>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">Age/sex</th>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">Diagnosis</th>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)"><italic>MLL-SEPT5</italic> fusion transcript</th>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">References</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">11.5 mo/F</td>
              <td valign="top" align="left" rowspan="1" colspan="1">AML with maturation</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>MLL</italic> exon 7-<italic>SEPT5</italic> exon 3</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Megonigal <italic>et al</italic>., 1998 [<xref rid="B8" ref-type="bibr">8</xref>]</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">2</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">13 mo/F</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">AML without maturation</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)"><italic>MLL</italic> exon 7-<italic>SEPT5</italic> exon 3</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Megonigal <italic>et al</italic>., 1998 [<xref rid="B8" ref-type="bibr">8</xref>]</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">3</td>
              <td valign="top" align="left" rowspan="1" colspan="1">39 yr/M</td>
              <td valign="top" align="left" rowspan="1" colspan="1">AML with maturation</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>MLL</italic> exon 6-<italic>SEPT5</italic> exon 4</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Tatsumi <italic>et al</italic>., 2001 [<xref rid="B5" ref-type="bibr">5</xref>]</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">4</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">23 mo/F</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Acute monocytic leukemia</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)"><italic>MLL</italic> exon 10-<italic>SEPT5</italic> exon 3</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Launay <italic>et al</italic>., 2014 [<xref rid="B9" ref-type="bibr">9</xref>]</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">5</td>
              <td valign="top" align="left" rowspan="1" colspan="1">32 yr/M</td>
              <td valign="top" align="left" rowspan="1" colspan="1">AML with maturation</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>MLL</italic> exon 10-<italic>SEPT5</italic> exon 3</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Gao <italic>et al</italic>., 2014 [<xref rid="B10" ref-type="bibr">10</xref>]</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">6</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">21 yr/M</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Acute monocytic leukemia</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)"><italic>MLL</italic> exon 8-<italic>SEPT5</italic> intron 2</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Present</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">7</td>
              <td valign="top" align="left" rowspan="1" colspan="1">22 yr/F</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Acute monocytic leukemia</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>MLL</italic> exon 10-<italic>SEPT5</italic> exon 3</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Present</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p>Abbreviations: F, female; M, male; mo, month; MLL, mixed lineage leukemia.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
